Skip to content


Call for Papers: Thematic Series 2019

           Series Title: Microvesicles and Tumor Microenvironment in Cancer Development and Resistance to Therapies
                                             New Content Item
The tumor microenvironment (TME) has an effect on tumor development, growth, and resistance to therapy. Continuous interactions and exchanges between tumor cells and the TME are involved in angiogenesis, tumor genetic diversity, immune escape, and metastasis.   

Molecular Cancer is delighted to present this series that aims to highlight significant findings and advances in our understanding of the role of the TME in cancer biology. Some areas of interest include, but are not limited to, hypoxia, microvesicles/exosomes, chemokines, carcinoma associated fibroblasts, tumor-infiltrating lymphocytes, and tumor associated macrophages and the clinical applications/drug development to target the TME and tumor cells.

We welcome submission of research articles, letters to the editor, and original reviews. The submission deadline is December 20th, 2018. To submit your manuscript, please use our online submission system available here
When finalizing the submission, use the drop-down menu in the 'Additional Information' tab to specify that you are submitting to this special issue.

New Content Item (1)

New Associate Editors Recruitment

Molecular Cancer invites you to join our team of academic editors in assessing manuscripts. For consideration, please send your CV to

Thematic Series Published in 2018

Oncogenic Signaling of Tyrosine Kinase in Cancer: Challenges and Therapeutic Opportunities-- the latest reviews in molecular cancer


Most accessed articles RSS

View all articles


Christophe Nicot, Kansas University Medical Center, USA

Aims and scope

Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science.

Read more

Impact Factor

Molecular Cancer has an Impact Factor of 7.776 and is ranked in the top 10% of both its JCR Categories. 

It is currently ranked at 27 out of 292 (Q1) in the Biochemistry and Molecular Biology category and 22 out of 222 (Q1) in the Oncology category of Journal Citation Reports.


2017 Journal Metrics